Response.
作者信息
Haines Ian E, Miklos George L Gabor
机构信息
Affiliations of authors: Department of Medical Oncology, Monash University at Cabrini Hospital, Malvern, Victoria 3144, Australia (IH); Atomic Oncology, Newport Beach, New South Wales 2106, Australia (GLGM).
出版信息
J Natl Cancer Inst. 2014 Apr 26;106(5):dju081. doi: 10.1093/jnci/dju081.
Abstract
摘要
相似文献
1
Response.
J Natl Cancer Inst. 2014 Apr 26;106(5):dju081. doi: 10.1093/jnci/dju081.
2
Response.
J Natl Cancer Inst. 2014 Feb;106(2):djt433. doi: 10.1093/jnci/djt433. Epub 2014 Jan 7.
3
Prostate cancer screening: biases and the need for consensus.
J Natl Cancer Inst. 2013 Oct 16;105(20):1522-4. doi: 10.1093/jnci/djt266. Epub 2013 Oct 3.
4
Re: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
J Natl Cancer Inst. 2014 Feb;106(2):djt432. doi: 10.1093/jnci/djt432. Epub 2014 Jan 7.
5
RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
J Natl Cancer Inst. 2014 Apr 26;106(5):dju079. doi: 10.1093/jnci/dju079.
6
Reducing prostate cancer deaths: unsupported speculation about the androgen deprivation hypothesis.
Eur Urol. 2014 Dec;66(6):973-4. doi: 10.1016/j.eururo.2014.06.051. Epub 2014 Jul 10.
7
Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
J Natl Cancer Inst. 2013 Oct 16;105(20):1534-9. doi: 10.1093/jnci/djt248. Epub 2013 Oct 3.
8
The prostate cancer conundrum.
J Natl Cancer Inst. 2003 Jul 2;95(13):930-1. doi: 10.1093/jnci/95.13.930.
9
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
J Natl Compr Canc Netw. 2018 May;16(5S):620-623. doi: 10.6004/jnccn.2018.0036.
10
[Surgical and medical treatment for localized prostate cancer].
Gan To Kagaku Ryoho. 2007 Jul;34(7):1002-5.
本文引用的文献
1
RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
J Natl Cancer Inst. 2014 Apr 26;106(5):dju079. doi: 10.1093/jnci/dju079.
2
Re: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
J Natl Cancer Inst. 2014 Feb;106(2):djt432. doi: 10.1093/jnci/djt432. Epub 2014 Jan 7.
3
Prostate cancer screening: biases and the need for consensus.
J Natl Cancer Inst. 2013 Oct 16;105(20):1522-4. doi: 10.1093/jnci/djt266. Epub 2013 Oct 3.
4
Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
J Natl Cancer Inst. 2013 Oct 16;105(20):1534-9. doi: 10.1093/jnci/djt248. Epub 2013 Oct 3.
5
Prostate cancer mortality in the Finnish randomized screening trial.
J Natl Cancer Inst. 2013 May 15;105(10):719-25. doi: 10.1093/jnci/djt038. Epub 2013 Mar 11.
6
Prostate-cancer mortality at 11 years of follow-up.
N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135.
7
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
Lancet. 2011 Dec 17;378(9809):2104-11. doi: 10.1016/S0140-6736(11)61095-7. Epub 2011 Nov 2.
8
Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7.
9
Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer.
Eur J Cancer. 2010 Nov;46(17):3082-9. doi: 10.1016/j.ejca.2010.09.033.
10
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.
Zotero 插件